<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00213460</url>
  </required_header>
  <id_info>
    <org_study_id>2000/103/HP</org_study_id>
    <nct_id>NCT00213460</nct_id>
  </id_info>
  <brief_title>Small Bowel Motor Impairment in Scleroderma: Results of a Prospective 5-year Manometric Follow-up</brief_title>
  <official_title>Small Bowel Motor Impairment in Scleroderma: Results of a Prospective 5-year Manometric Follow-up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <brief_summary>
    <textblock>
      Small bowel involvement is still recognized to be associated with great morbidity and&#xD;
      mortality in SSc patients, leading particularly to malabsorption and intestinal&#xD;
      pseudo-obstruction. Intestinal disorders directly related to SSc have, in fact, been reported&#xD;
      to be one of the most common causes of death.&#xD;
&#xD;
      In a previous prospective study, we have demonstrated the high prevalence of small intestinal&#xD;
      involvement in SSc patients, using upper intestinal manometry; in turn, 88% of our SSc&#xD;
      patients had upper intestinal motor disturbances. However, to date, no authors have yet&#xD;
      analyzed the course of upper intestinal motor dysfunction in SSc.&#xD;
&#xD;
      The aims of this study were therefore to assess the 5-year course of small bowel motor&#xD;
      disorders, using manometry in patients with systemic sclerosis (SSc), and to investigate for&#xD;
      an association between upper intestinal motor dysfunction outcome and other clinical&#xD;
      manifestations of SSc.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2001</start_date>
  <completion_date type="Actual">July 2003</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <condition>Systemic Sclerosis</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with systemic sclerosis, who had an upper intestinal tract manometry 5 years&#xD;
             before, with:&#xD;
&#xD;
               -  age over 18 years&#xD;
&#xD;
               -  written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregant women&#xD;
&#xD;
          -  patients with psychiatric conditions&#xD;
&#xD;
          -  unwritten informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabelle MARIE, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Rouen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Rouen</name>
      <address>
        <city>Rouen</city>
        <state>Rouen Cedex</state>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2005</study_first_posted>
  <last_update_submitted>April 15, 2013</last_update_submitted>
  <last_update_submitted_qc>April 15, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scleroderma, Systemic</mesh_term>
    <mesh_term>Scleroderma, Diffuse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

